Israel’s Respinova developed Pulsehaler to help COPD patients improve their lungs and avoid ventilation. Repinova is now preparing for clinical trials in Israel on patients suffering from acute respiratory distress syndrome (ARDS) as caused by Covid-19.

https://www.israel21c.org/copd-innovation-may-keep-covid-patients-off-ventilators/